A detailed history of Decheng Capital LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 21,177 shares of ACLX stock, worth $1.67 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
21,177
Previous 1,177 1699.24%
Holding current value
$1.67 Million
Previous $65 Million 2622.47%
% of portfolio
0.42%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$50.91 - $86.61 $1.02 Million - $1.73 Million
20,000 Added 1699.24%
21,177 $1.77 Billion
Q2 2024

Aug 14, 2024

BUY
$49.74 - $66.98 $58,543 - $78,835
1,177 New
1,177 $65 Million

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.46B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Decheng Capital LLC Portfolio

Follow Decheng Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital LLC with notifications on news.